SequenomLaboratories

@SequenomLabs

Best-in-class laboratory testing services with a focus on prenatal diseases and conditions. Read our social policy:

San Diego, California
laboratories.sequenom.com
Vrijeme pridruživanja: rujan 2014.
98 fotografija ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @SequenomLabs

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @SequenomLabs

  1. 6. tra 2016.

    Today our CMO, Daniel Grosu, is discussing using biomarkers for early disease detection at Libson:

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  2. 28. ožu 2016.

    Great feature on , featuring Dr. Dennis Lo. Discover a child's medical destiny before they're even born. by

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  3. 25. ožu 2016.

    Premature birth is the #1 killer of babies. But it doesn't have to be! MARCH FOR BABIES!

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  4. proslijedio/la je Tweet
    18. ožu 2016.

    Study yields positive results for noninvasive test from

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  5. 11. ožu 2016.

    At , attend today's poster session from to hear Sequenom's Jason Chibuk and Sidra Boshes present on clinical experience with NIPT.

    2 proslijeđena tweeta 1 korisnik označava da mu se sviđa
  6. 10. ožu 2016.

    Tonight at Sequenom's Mathias Ehrich offers "Liquid Biopsy as a Substitute for Tissue Biopsy Using a Comprehensive NGS Panel"

    3 proslijeđena tweeta
  7. 10. ožu 2016.

    Attending ? Today at 4pm, “Clinical Implementation of cfDNA,” is led by Sequenom CMO Dr. Daniel Grosu.

    1 proslijeđeni tweet
  8. 9. ožu 2016.

    Got Genetics? While at , stop by Sequenom booth #833 to learn how much information your NIPT may be missing.

    2 proslijeđena tweeta 1 korisnik označava da mu se sviđa
  9. 8. ožu 2016.

    How much info is missed by “conventional” NIPT? Learn today at 5 pm at with Sequenom CMO Dr. Daniel Grosu:

    3 proslijeđena tweeta 1 korisnik označava da mu se sviđa
  10. 7. ožu 2016.

    Sequenom CMO Dr. Daniel Grosu will speak about genome-wide prenatal cell free DNA testing tomorrow at :

    3 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
  11. 5. ožu 2016.

    Sequenom proudly supports the March of Dimes fight against birth defects, premature birth and infant mortality.

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  12. 4. ožu 2016.

    Expecting moms - check out some helpful hits from . Pregnancy How-to: Stress Relief

    5 proslijeđenih tweetova 3 korisnika označavaju da im se sviđa
  13. 1. ožu 2016.

    Happy to support the campaign! Learn more on:

    1 proslijeđeni tweet
  14. 29. velj 2016.

    Rare Disease Day is today. Join us at MaterniT21 PLUS in raising awareness.

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
  15. 25. velj 2016.

    Today we announced positive results from our clinical validation study on the MaterniT® GENOME test. Download here:

    3 proslijeđena tweeta
  16. 24. velj 2016.

    Questions about trisomies, carrier screening, and other issues and tests related to ? Our FAQ can help:

  17. 23. velj 2016.

    Some easy-to-understand info on chromosomal conditions from our friends at March of Dimes

    1 proslijeđeni tweet
  18. 22. velj 2016.

    Dr. Ronald Wapner of Columbia University states that cfDNA testing should be part of prenatal care

    2 korisnika označavaju da im se sviđa
  19. 15. velj 2016.

    Sure, moms know about hyperemesis gravidarum but what are other signs you’re carrying a girl?

    1 reply 3 proslijeđena tweeta
  20. 12. velj 2016.

    Are chromosomal conditions inherited? Sometimes, but not always:

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa

@SequenomLabs još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·